sever
bacteri
communityacquir
pneumonia
wellknown
problem
sever
viral
infect
might
underestim
due
low
awar
hand
introduct
molecular
diagnost
method
significantli
improv
epidemiolog
investig
viral
pneumonia
icu
recent
year
increas
potenti
detect
wide
array
virus
fact
recent
studi
virus
account
total
infect
patient
admit
intens
care
unit
icu
sever
respiratori
distress
addit
emerg
new
respiratori
virus
human
coronaviru
hcov
sar
hcovmer
influenza
underscor
role
virus
sever
respiratori
infect
still
role
viral
agent
influenza
rhinoviru
hrv
parainfluenza
virus
respiratori
syncyti
viru
rsv
hcov
frequent
detect
respiratori
sampl
icu
patient
fulli
appreci
influenza
season
increas
number
laboratoryconfirm
influenza
admiss
icu
death
compar
previou
season
observ
northern
hemispher
gener
emerg
inher
virul
virus
cours
given
season
overlook
differ
host
factor
respons
sever
outcom
influenza
infect
suggest
ie
pregnanc
obes
specif
observ
influenza
viru
pandem
genet
chang
may
increas
transmiss
replic
effici
tissu
tropism
rang
instanc
singl
amino
acid
chang
ha
gene
associ
increas
viru
replic
lower
respiratori
tract
lrt
wors
clinic
outcom
howev
still
unclear
mutat
emerg
evolv
consolid
andor
disappear
context
dynam
viral
popul
chang
infect
aim
studi
describ
frequenc
respiratori
virus
patient
admit
icu
winterspr
season
multicent
prospect
observ
studi
ii
monitor
presenc
polymorph
posit
ha
gene
influenza
strain
iii
investig
dynam
influenza
viru
popul
lrt
icu
patient
use
sanger
next
gener
sequenc
ng
decemb
april
nasal
swab
ns
nasopharyng
aspir
npa
bronchoalveolar
lavag
bal
broncho
aspir
brasp
collect
patient
acut
respiratori
failur
requir
icu
admiss
lombardi
million
inhabit
prospect
analyz
part
region
influenza
surveil
plan
analys
central
molecular
virolog
unit
fondazion
ircc
policlinico
san
matteo
pavia
depart
biomed
scienc
health
univers
milan
sever
respiratori
syndrom
defin
acut
onset
week
respiratori
failur
hypoxemia
ratio
mmhg
posit
endexpiratori
pressur
peep
noninvas
cpap
bilater
opac
chest
imag
sampl
posit
influenza
viru
analyz
presenc
polymorph
posit
ha
gene
addit
group
patient
mild
respiratori
syndrom
requir
hospit
includ
studi
control
retrospect
studi
perform
accord
region
surveil
prepared
plan
dgr
dec
dgr
jun
guidelin
institut
review
board
use
biolog
specimen
scientif
purpos
keep
italian
law
dlg
approv
ethic
commite
fondazion
ircc
policlinico
san
matteo
pavia
itali
diagnost
clinic
manag
patient
admit
hospit
lombardi
region
sever
moder
influenza
like
ill
ili
includ
prospect
influenza
detect
subtyp
sequenc
latter
two
central
two
region
refer
laboratori
mild
respiratori
infect
specimen
collect
sentinel
practition
anonym
analyz
refer
laboratori
milan
accord
nation
surveil
plan
influnet
inform
consent
influenza
genotyp
requir
sinc
patient
sever
mild
ili
includ
region
diagnost
clinic
manag
protocol
data
anonym
analyz
accord
region
surveil
prepared
plan
mild
ili
sampl
collect
anonym
analyz
framework
nation
surveil
plan
influnet
nucleic
acid
respiratori
sampl
extract
use
instrument
dsp
kit
complex
protocol
accord
manufactur
instruct
qiagen
qiagen
hilden
germani
panel
laboratorydevelop
realtim
rtpcr
realtim
pcr
use
abl
detect
quantifi
follow
virus
influenza
viru
b
includ
subtyp
determin
hrv
rsv
type
b
human
metapneumoviru
hmpv
bacteri
fungal
cultur
perform
use
standard
techniqu
quantifi
bal
brasp
specimen
complet
influenza
ha
gene
amplifi
directli
clinic
specimen
use
superscriptiii
onestep
rtpcr
amplif
kit
invitrogen
carlsbad
usa
specif
primer
avail
upon
request
purifi
pcr
product
sequenc
use
bigdy
termin
cyclesequenc
kit
appli
biosystem
foster
citi
usa
abi
prism
genet
analyz
appli
biosystem
foster
citi
usa
sequenc
assembl
use
sequench
softwar
version
gene
code
corpor
ann
arbor
usa
nucleotid
align
construct
use
clustalw
program
embed
mega
version
softwar
phylogenet
tree
gener
mean
maximum
likelihood
method
kimura
evolutionari
model
use
mega
version
softwar
bootstrap
analysi
replic
perform
sanger
sequenc
origin
studi
submit
genbank
databas
access
number
primer
target
influenza
ha
gene
span
codon
use
amplifi
region
contain
codon
previous
report
synthesi
cdna
reaction
carri
use
transcriptor
high
fidel
cdna
synthesi
kit
roch
diangnost
gmbh
ul
extract
rna
amplif
perform
use
faststart
highfidel
pcr
system
kit
roch
appli
scienc
follow
reagent
mix
extract
dna
buffer
primer
um
pcr
grade
nucleotid
mix
dntp
faststart
highfidel
enzym
blend
pcr
grade
water
cycl
condit
amplif
follow
min
cycl
min
final
extens
cycl
min
amplicon
purifi
agencourt
ampur
xp
magnet
bead
beckman
coulter
high
wycomb
uk
quantifi
quantit
picogreen
dsdna
assay
kit
invitrogen
life
technolog
paisley
uk
minifluoromet
turner
biosystem
sunnyval
ca
dilut
perform
amplicon
pool
equimolar
concentr
mixtur
purifi
agencourt
ampur
xp
magnet
bead
beckman
coulter
high
wycomb
uk
dilut
moleculesul
purifi
pool
clonal
amplifi
emuls
pcr
empcr
follow
empcr
amplif
manual
gs
junior
titanium
total
enrich
bead
deposit
picotitrepl
ptp
devic
sequenc
use
gs
junior
system
roch
diagnost
west
sussex
uk
sequenc
data
obtain
standard
flowgram
format
sff
file
gs
run
processor
qualitycontrol
filter
read
trim
use
manufactur
default
paramet
see
sequenc
system
softwar
manual
version
sff
data
file
analyz
use
gs
amplicon
variant
analyz
ava
version
roch
life
scienc
branford
ct
read
trim
use
multiplex
identifi
mid
sampl
map
use
refer
fasta
ha
sequenc
strain
identif
variant
made
use
default
ava
set
consid
chang
whose
frequenc
least
ie
three
time
insert
error
rate
true
variabl
highest
frequenc
proceduralexperiment
error
variant
defin
viru
least
one
mutat
nucleotid
given
site
nucleotid
sequenc
analyz
continu
variabl
ie
viral
load
variant
number
compar
use
mannwhitney
u
test
independ
nonparametr
data
spearman
rank
correl
coeffici
use
correl
analysi
nonparametr
data
analys
two
tail
perform
use
graphpad
prism
version
graphpad
softwar
inc
ca
usa
pvalu
consid
statist
signific
total
respiratori
sampl
patient
admit
icu
sever
respiratori
syndrom
analyz
urt
specimen
ns
npa
lrt
specimen
bal
brasp
sixtynin
patient
posit
respiratori
viral
infect
neg
fig
posit
episod
singl
viru
observ
episod
dual
viral
infect
detect
fig
influenza
frequent
viru
observ
patient
subtyp
singl
coinfect
detect
patient
subtyp
singl
coinfect
detect
hrv
detect
patient
rsv
influenza
b
three
patient
dual
viral
infect
observ
influenza
hrv
pt
influenza
b
rsv
pt
influenza
hcov
pt
subset
patient
addit
inform
bacterialfung
coinfect
avail
among
coinfect
influenza
candida
spp
aspergillu
spp
influenza
k
pneumonia
neg
data
shown
among
icu
patient
pair
sampl
urt
lrt
avail
urt
specimen
avail
lrt
specimen
avail
median
viral
load
lrt
sampl
n
higher
observ
urt
sampl
n
vs
rna
copiesml
p
similarli
median
viral
load
urt
sampl
control
patient
slightli
higher
observ
urt
icu
patient
although
differ
reach
signific
p
restrict
analysi
icu
patient
pair
sampl
influenza
load
significantli
higher
lrt
secret
median
rna
copiesml
rang
compar
urt
sampl
median
rna
copiesml
rang
p
addit
median
differ
lrt
urt
sampl
copiesml
rang
rna
copiesml
interestingli
two
case
urt
sampl
neg
presenc
high
viral
load
lrt
total
ns
bal
brasp
respiratori
sampl
icu
patient
well
ns
patient
mild
respiratori
syndrom
analyz
sanger
ng
sequenc
complet
ha
sequenc
perform
baselin
sampl
icu
control
patient
sequenc
data
obtain
respiratori
sampl
icu
patient
due
low
viral
load
sequenceneg
sampl
urt
specimen
overal
nucleotid
ident
ha
sequenc
studi
refer
vaccin
strain
rang
influenza
strain
belong
subgroup
observ
worldwid
fig
subgroup
character
constitut
polymorph
addit
amino
acid
polymorph
sporad
observ
ha
sequenc
strain
detail
strain
carri
chang
strain
chang
chang
chang
chang
among
icu
patient
influenzasequenc
strain
carri
wildtyp
codon
four
strain
carri
mixtur
posit
tabl
detail
two
patient
mixtur
one
mixtur
mixtur
identifi
lrt
sampl
ng
use
analyz
dynam
influenza
popul
partial
ha
region
span
codon
ng
analysi
success
perform
icu
control
patient
icu
patient
ng
data
obtain
urt
sampl
due
low
viral
load
total
read
obtain
ng
platform
averag
amplicon
length
nt
median
rang
sequenc
read
obtain
per
sampl
allow
detect
quantif
minor
mutat
cutoff
valu
among
icu
patient
n
number
variant
lrt
sampl
median
rang
significantli
higher
observ
urt
sampl
median
rang
p
fig
similarli
number
variant
observ
urt
sampl
icu
patient
median
rang
higher
observ
urt
sampl
control
patient
median
rang
p
among
ten
patient
pair
sampl
tabl
number
variant
perform
pair
urt
lrt
sampl
patient
patient
could
perform
lrt
sampl
due
low
viral
load
urt
sampl
tabl
three
addit
patient
tabl
number
variant
determin
lrt
sampl
overal
mutat
gna
codon
observ
lrt
sampl
tabl
patient
number
mix
variant
also
suggest
sanger
mix
electropherogram
detect
strain
detect
urt
icu
n
control
n
patient
carri
polymorph
frequenc
one
patient
ng
identifi
chang
frequenc
lower
lrt
sampl
note
sampl
ng
analysi
identifi
polymorph
show
overal
lower
number
variant
median
rang
variant
compar
sampl
mix
variant
posit
median
rang
variant
p
followup
lrt
sampl
collect
limit
number
patient
n
case
longitudin
ng
analysi
viral
popul
possibl
four
patient
receiv
antiinfluenza
treatment
analyz
period
report
fig
baselin
case
mixtur
mutat
codon
observ
fig
sampl
patient
viral
load
number
variant
decreas
simultan
wildtyp
amino
acid
detect
day
admiss
sampl
patient
initi
decreas
viral
load
number
variant
associ
presenc
wildtyp
amino
acid
howev
sudden
increas
viral
load
number
variant
associ
reemerg
low
frequenc
patient
lrt
sampl
day
onset
symptom
avail
decreas
viral
load
number
variant
associ
signific
chang
viral
popul
posit
present
prospect
observ
studi
incid
respiratori
virus
investig
respiratori
sampl
patient
admit
icu
influenza
season
influenza
virus
commonli
detect
pathogen
second
identifi
viru
hrv
frequenc
close
keep
larg
prospect
studi
describ
aetiolog
communityacquir
pneumonia
us
clinic
relev
noninfluenza
viral
infect
icu
patient
remain
controversi
howev
impact
noninfluenza
virus
appear
import
previous
thought
thu
virus
includ
diagnost
panel
studi
strain
outnumb
ratio
approach
patient
admit
icu
northern
itali
find
contrast
epidemiolog
scenario
observ
sentinel
sourc
world
health
organ
nation
influenza
center
fact
predomin
influenza
strain
europ
itali
http
observ
period
among
icu
patient
median
influenza
load
lrt
sampl
significantli
higher
observ
urt
sampl
patient
group
keep
previou
observ
differ
viral
load
evid
pair
sampl
case
except
one
viral
load
higher
lrt
urt
interestingli
almost
patient
viral
load
urt
undetect
presenc
high
viral
load
lrt
reason
hypothes
sever
infect
initi
replic
influenza
urt
follow
spread
influenza
lrt
icu
admiss
usual
sever
day
onset
clinic
symptom
clinic
sampl
collect
laboratori
diagnosi
moment
influenza
viru
might
alreadi
clear
urt
immun
system
lrt
viral
shed
persist
therefor
find
underlin
import
appropri
sampl
collect
especi
patient
sever
infect
consid
mutat
ha
gene
influenza
strain
strictli
associ
increas
clinic
sever
studi
presenc
polymorph
posit
strain
assess
sanger
ng
sequenc
patient
sever
infect
patient
hospit
mild
respiratori
syndrom
strain
belong
influenza
clade
circul
europ
period
sampl
collect
intrahost
viral
divers
assess
use
ng
respiratori
sampl
determin
number
variant
overal
greater
number
viru
variant
observ
lrt
suggest
differ
viral
kinet
pattern
urt
compar
lrt
patient
sever
influenza
infect
mutat
known
associ
increas
clinic
sever
observ
ltr
sampl
icu
patient
urt
sampl
icu
control
patient
wild
type
polymorph
observ
frequenc
chang
keep
previou
observ
report
although
data
confirm
associ
mutat
diseas
sever
icu
patient
show
specif
ha
mutat
among
viral
popul
lung
therefor
reason
hypothes
one
virul
determin
involv
sever
influenza
infect
nevertheless
patient
comorbid
perexist
host
genet
factor
may
contribut
diseas
sever
demonstr
vitro
vivo
strain
carri
bind
sialic
acid
effici
wherea
strain
broader
tropism
sialic
acid
therefor
replic
effici
lrt
keep
find
seri
popul
observ
lrt
sampl
unfortun
inform
regard
quasispeci
popul
urt
could
obtain
due
low
viru
load
viral
divers
evalu
sequenti
lrt
sampl
show
sever
pattern
popul
evolut
basi
find
due
limit
number
case
major
conclus
drawn
viral
popul
dynam
lrt
studi
limit
frequenc
differ
respiratori
virus
could
bias
role
center
refer
laboratori
diagnosi
confirm
sever
influenzalik
ill
ii
quasispeci
analysi
focus
codon
complet
genom
sequenc
would
provid
exhaust
inform
iii
portion
icu
patient
upper
respiratori
sampl
avail
therefor
diagnosi
perform
partial
bias
group
sampl
conclus
studi
show
presenc
mutat
associ
increas
clinic
sever
least
icu
patient
lrt
infect
great
number
variant
high
viral
load
observ
lrt
compar
urt
sampl
final
intrahost
evolut
analysi
show
presenc
differ
dynam
viral
popul
lrt
patient
hospit
icu
sever
influenza
infect
